Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
THERAPEUTIC ANTIBODY-BASED FUSION PROTEIN
Document Type and Number:
Japanese Patent JPH0687898
Kind Code:
A
Abstract:

PURPOSE: To provide a fused protein wherein a part of antibody is fused with a biologically active ligand. The fused protein useful as antitumor agents or the like, which has an amplified antitumor immune response and is able to deliver biologically active ligand molecule to a specific target cell or tissue.

CONSTITUTION: The objective fused protein containing a portion of immunoglobulin molecule, which is able to deliver the fused protein to a specific target cell or tissue, and the biologically active ligands, is prepared by first constructing a recombinant gene by binding a gene encoding all or part of an immunoglobulin such as antitumor antigenic monoclonal antibody variable region which is comprised of regions encoded by V gene, D gene, J gene or the like, as the targeting portion of molecule capable of directing the fusion protein to an intended cell or tissue, and a biologically active ligand which is a lymphokine, including interleukin-2, to a part of vector polylinker, then introducing the recombinant gene thus obtained into a host cell to transform, and culturing the transformed cell.


Inventors:
HENRII PERII FUERU JIYUNIA
MAAJITSUTO AN GEIRU
Application Number:
JP21667491A
Publication Date:
March 29, 1994
Filing Date:
January 22, 1991
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BRISTOL MYERS SQUIBB CO
International Classes:
A61K39/395; A61K47/48; A61P35/00; C07K14/00; C07K14/46; C07K14/52; C07K14/54; C07K14/55; C07K16/00; A61K38/00; C07K16/30; C07K16/46; C07K19/00; C12N15/09; C12P21/02; C12P21/08; C12R1/91; (IPC1-7): C07K15/12; A61K37/02; A61K39/395; C12N15/62; C12P21/02
Attorney, Agent or Firm:
Minoru Nakamura (7 outside)